Clinical Trial ECOGTHO4508-M


Three-Arm Randomized Phase II Study of Carboplatin and Paclitaxel in Combination with Cetuximab, IMC-A12 or Both for Advanced Non-small Cell Lung Cancer Patients WhoWill Not Receive Bevacizumab-based Therapy

Principal Investigator(s)

John Murray


  • Protocol No. ECOGTHO4508-M
  • Open Date: 12/07/2010
  • Staging: Phase II
  • Age Group: Adults
  • Scope: National
  • Objective:
  • Disease Sites:
  • Therapies: Chemotherapy - cytotoxic
  • Drugs: Carboplatin; Cetuximab; Cetuximab (Erbitux); IMC-A12; Paclitaxel
  • Participating Institutions: Meharry Medical College; Baptist Hospital
  • Secondary Protocol No: Not Specified



Learn More

You do not have JavaScript enabled. This site works better with JavaScript turned on.